PlushCare Launches Enhanced Online Weight Loss Program to Expand National Access to GLP-1 Prescriptions Through Board-Certified Doctors
San Francisco, June 10, 2025 (GLOBE NEWSWIRE) --
PlushCare, a leading virtual healthcare platform, has announced a significant upgrade to its online Weight Loss Program, enabling greater access to GLP-1-based prescription treatments such as semaglutide through board-certified physicians. This development marks a critical milestone in the company's mission to provide affordable, clinically supervised weight management across the United States.
Accessible at https://plushcare.com/weight-loss/, the updated platform streamlines the process for eligible adults to consult with licensed physicians, receive lab work if necessary, and access customized treatment plans—all from the comfort of their homes.
'We're committed to making evidence-based weight loss solutions more accessible through modern telehealth,' said a PlushCare spokesperson. 'Our program is designed to connect people with experienced doctors who can evaluate eligibility for medications like GLP-1s and deliver a personalized plan that fits their health goals.'
Expanded Features for 2025
The revamped Weight Loss Program now includes:
Nationwide Access to medical providers via secure telehealth appointments
Eligibility Evaluation for FDA-approved medications, including semaglutide
Personalized Plans tailored to each user's metabolic profile
Optional Lab Testing with integrated results for precision treatment
Transparent Pricing with no insurance required
The platform is optimized for mobile and desktop users, offering a seamless experience from appointment scheduling to prescription delivery.
Addressing a Growing National Health Concern
According to the CDC, over 40% of U.S. adults struggle with obesity, with rising demand for effective clinical support. PlushCare's integrated virtual care model delivers a scalable solution that removes traditional geographic and scheduling barriers.
Patients can typically get started in under 15 minutes by completing an intake form and booking a same-day appointment with a licensed doctor. If clinically appropriate, a prescription is sent to their preferred pharmacy.
About PlushCare
PlushCare is a virtual primary care and mental health platform that connects patients with top U.S. medical professionals through its secure telehealth platform. With a commitment to quality care, convenience, and evidence-based treatment, PlushCare is redefining access to modern healthcare.
For more information, visit https://plushcare.com.
Media Contact:PlushCare Media RelationsEmail: press@plushcare.comWebsite: https://plushcare.comAddress: 345 California Street, Suite 600, San Francisco, CA 94105, United States
SOURCE: PlushCare
Disclaimer: This release contains forward-looking statements and should not be considered medical advice. All treatments are subject to clinical evaluation and provider discretion.
CONTACT: Email: press@plushcare.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Lawmakers Press FDA to Target Knockoff Weight-Loss Drugs
(Bloomberg) -- Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks. Trump Awards $1.26 Billion Contract to Build Biggest Immigrant Detention Center in US The High Costs of Trump's 'Big Beautiful' New Car Loan Deduction Can This Bridge Ease the Troubled US-Canadian Relationship? Salt Lake City Turns Winter Olympic Bid Into Statewide Bond Boom Trump Administration Sues NYC Over Sanctuary City Policy On Friday, a group of more than 80 bipartisan lawmakers asked the US Food and Drug Administration to stop counterfeit and copycat versions of GLP-1 drugs like Wegovy and Zepbound from flooding the market — a problem that emerged over the last year. 'We are concerned about recent reports revealing a surge in illegal and counterfeit anti-obesity medications,' they wrote in a letter to FDA Commissioner Marty Makary. 'Undoubtedly, illegal counterfeit medications pose an increased risk to patient safety with sometimes fatal consequences.' The group — spearheaded by Representatives Richard Hudson of North Carolina and Herb Conaway of New Jersey — asked the agency to ramp up enforcement over illegally imported weight-loss drugs. They suggested issuing warning letters and better monitoring non-compliant online retailers and so-called compounding pharmacies that sell the medicines. The lawmakers also said the FDA should work in tandem with US Customs and Border Patrol agents to stop Chinese entities from shipping unsafe weight-loss drugs into the US. They requested an update on the FDA's efforts by July 30, given the 'urgency' of the situation. A spokesperson for the FDA said the agency will work with the US Department of Health and Human Services to provide a 'complete and thorough' response to the issues raised in the lawmakers' letter. 'Any effort to undermine America's supply of safe medicines is an issue that FDA takes seriously,' the spokesperson said. 'And we are deeply committed to strengthening the oversight of imported products at US ports of entry.' In recent years, the popularity of GLP-1 drugs has led to an explosion of copycats and counterfeits made by companies seeking to capitalize on the hype. State-licensed pharmacies were temporarily allowed to make copies of the drugs during a supply shortage, but are no longer permitted to do so after Novo Nordisk A/S and Eli Lilly & Co. boosted production. Still, some pharmacies have refused to wind down their operations while others have pivoted to selling the drugs in lower doses in order to avoid regulatory scrutiny. Counterfeit drugs are made by unregistered entities typically using illegally imported ingredients. As recently as April, there continue to be instances when counterfeit Ozempic pens covertly enter the drug supply chain undetected. Some patients are also purchasing ingredients directly from online sellers in an attempt to make the drugs themselves at home. In both cases, the medications don't go through the same rigorous approval process as brand-name drugs made by Novo and Lilly. Experts worry the lack of oversight is putting patients at risk. The FDA has said it's aware of hospitalizations potentially linked to the copycat drugs, but that adverse events are likely being underreported. 'We support the bi-partisan call for the FDA to crack down on counterfeit and illegally sold weight-loss drugs,' said a spokesperson for Hims & Hers Health Inc., one of the telehealth firms that sells compounded GLP-1s. 'We appreciate lawmakers' recognition that legitimate compounded medications dispensed by state-regulated pharmacies are not counterfeit. Patient safety must always come first.' Novo and Lilly have discouraged consumers from using compounded and counterfeit products, including suing telehealth firms that sell the copycat versions and working with border agents to seize illegal shipments. Under the Biden administration, the companies repeatedly urged the FDA to take action, but the agency mostly limited its actions to issuing consumer warnings — even as its top drug official publicly acknowledged safety concerns. Under the Trump administration, the HHS has also focused more heavily on other issues, such as banning food dyes and examining vaccine schedules. Meanwhile, lawmakers are ramping up their calls for action. State attorneys and other lawmakers have sent letters to the FDA and Federal Trade Commission advocating for greater transparency around the treatments and more scrutiny around marketing practices. (Updates with statement from FDA in sixth and seventh paragraphs.) Burning Man Is Burning Through Cash Confessions of a Laptop Farmer: How an American Helped North Korea's Wild Remote Worker Scheme It's Not Just Tokyo and Kyoto: Tourists Descend on Rural Japan Elon Musk's Empire Is Creaking Under the Strain of Elon Musk A Rebel Army Is Building a Rare-Earth Empire on China's Border ©2025 Bloomberg L.P. Sign in to access your portfolio
Yahoo
3 minutes ago
- Yahoo
ChristianaCare opens neighborhood hospital in Chester County, Pennsylvania
ChristianaCare is opening its first neighborhood hospital in the company's 188-year history over the Delaware line northwest of Hockessin in Chester County, Pennsylvania. ChristianaCare Hospital, West Grove, is scheduled to open in mid-August at 1015 W. Baltimore Pike, West Grove, offering a new model of emergency and acute care in a modern, easy-to-access setting. The 20,000-square-foot hospital will be open 24 hours a day, seven days a week. Developed in partnership with Emerus Holdings Inc., the nation's leading developer of neighborhood hospitals, this facility will be staffed with board-certified emergency physicians, skilled nurses and clinical specialists. 'It's an honor and privilege to expand access to high-quality care for our neighbors in southern Chester County,' said Janice Nevin, president and CEO of ChristianaCare, in a press release. 'We will be opening our doors for the families in this community with a steadfast commitment to being their trusted health care partner. We're grateful for the opportunity to bring love and excellence to those we will serve.' Nevin said the project has received strong local support and was made possible in part by generous grants from the Commonwealth of Pennsylvania and the Chester County Board of Commissioners – Josh Maxwell, Marian Moskowitz and Eric Roe – whose leadership helped bring this vision to life. ChristianaCare Hospital, West Grove, is designed to meet a wide range of everyday medical needs with: A full-service emergency department with 10 treatment rooms. A 10-bed inpatient unit for overnight stays, observation and diagnostics. Advanced imaging and lab services, including ultrasound, CT scan and X-ray. Virtual access to specialists in such areas as cardiology, critical care and infectious disease. The emergency department is equipped to treat conditions such as falls, injuries, heart attacks and strokes. Patients requiring surgery or more complex care will be stabilized and transferred to a hospital with more expanded service offerings based on the clinical needs of the patient. 'This neighborhood hospital brings the right mix of services to support the health and well-being of our neighbors,' said Pauline Corso, president of ambulatory network continuity and growth at ChristianaCare. 'We're excited to bring care close to home to meet the needs of the community. We're here to stay and grow alongside this community.' As part of its long-term investment in the West Grove Campus, ChristianaCare has also purchased the building at 900 W. Baltimore Pike, across the street from the hospital. This facility houses a ChristianaCare primary care practice and imaging services, offering walk-in X-rays and scheduled mammography and ultrasound appointments. This health center will continue to evolve to meet the growing needs of the community, Nevin said. More hospital news: What Medicaid, Medicare cuts could mean for Delaware's hospitals, especially in rural areas More expansion plans in southeastern Pennsylvania ChristianaCare is expanding its neighborhood hospital model to address care gaps across southeastern Pennsylvania, Nevin said. New hospitals are being planned for Aston and Springfield Townships in Delaware County, with the Aston location under construction and expected to open in late 2026. In addition, ChristianaCare was the successful bidder for Crozer Health outpatient centers in Glen Mills, Havertown, Broomall and Media, further strengthening its regional footprint and ability to deliver timely, high-quality care. More on Crozer Health ChristianaCare to take on 5 Crozer Health outpatient locations with $50M bid History of care in southeastern Pennsylvania and Delaware ChristianaCare's presence in southeastern Pennsylvania is long-standing. The organization provides primary care at three Chester County locations – Kennett Square, Jennersville and West Grove – and recently opened a cardiology practice in West Grove. In neighboring Delaware County, the Concord Health Center in Chadds Ford offers a wide range of services, including primary care, women's health, sports medicine and behavioral health. Together, these sites serve as the medical home for more than 25,000 residents, underscoring ChristianaCare's deep commitment to delivering accessible, high-quality care where it's needed most, Nevin said. Headquartered in Wilmington, Delaware, ChristianaCare also has a network of primary care and outpatient services, home health care, urgent care centers, four hospitals with a total of 1,440 beds, a freestanding emergency department, a level-one trauma center and a level-three neonatal intensive care unit, a comprehensive stroke center, the Gene Editing Institute and regional centers of excellence in heart and vascular care, cancer care and women's health. Reporter Ben Mace covers real estate, development and business news. Reach him at rmace@ This article originally appeared on Delaware News Journal: ChristianaCare opens neighborhood hospital in southeastern Pennsylvania Solve the daily Crossword
CBS News
5 minutes ago
- CBS News
Boston renter says mice, bed bug problem has gotten worse, warns against used furniture
Boston's rodent and bed bug problem may be getting worse. A man who rents on Mission Hill says his landlord has been trying to get rid of the pests for months, and he's not alone. Fritz, who wanted to remain anonymous, said he's been experiencing bed bugs and mice at his apartment on Hillside Street on Mission Hill. He's been living there for almost a year. He started noticing mice in the building about six months ago. "We've been seeing four or five that we've caught then we've put everything in jars that mice can't get to, but we are still seeing mice," Fritz said. "Then we also had an incident with bed bugs." Fritz said after multiple exterminator visits, the problem is not going away in their unit. "There were droppings all over the pantry, a little bit on the floor," Fritz said. "It also just made it kind of gross to go cook in the kitchen when there may be mice droppings. We would clean it up and then a couple days later they obviously came back. Just makes it really tough." "We understand that neighborhoods with high rates of tenant turnover are particularly vulnerable to bed bug infestations-especially when used furniture is brought into homes or when residents attempt do-it-yourself treatments," Boston Inspectional Services said. "We strongly encourage anyone experiencing an infestation to immediately notify their landlord so that prompt and proper treatment can begin." Which is something Fritz has done on multiple occasions. "I think the message the landlord is sending is that he's doing everything he can. But from our perspective every day we are still seeing mice and bed bugs," Fritz said. "Makes it tough to stay there especially with the high rent prices." He also says he's been spending less time at his apartment because the issue hasn't been resolved. "I have heard that it's gotten worse," Fritz said. "I did speak with Terminix, and they said that they've seen an uptick in especially the Boston area, specifically with college students." Fritz, who just graduated college last year, warns college students who are getting ready to move back into their apartments soon to avoid used furniture. "It may seem like a good deal, a $50 couch but definitely worth it to just go and buy a new one in my opinion," Fritz said. "Or if you are getting used furniture, definitely make sure you are at least checking it, making sure there are no bed bugs on it, because you will be paying a lot more in exterminator fees than you will be in just buying the new property."
